Results 191 to 200 of about 4,346,534 (345)

Association of baseline HBcAg and HBV DNA with persistent detectability of HBV RNA during NA therapy. [PDF]

open access: yesPLoS One
Wu L   +10 more
europepmc   +1 more source

Liver organoids: modelling complexity in homeostasis and disease

open access: yesFEBS Letters, Volume 600, Issue 21, Page 3265-3285, November 2026.
Studying liver in vitro has been challenging because simple 2D cell cultures fail to capture liver's cellular and architectural complexity. To bridge this gap, scientists increasingly use organoids, 3D liver models which better mimic liver composition and function. This review examines recent advances in liver organoid complexity and realism, discusses
Anna M. Dowbaj, Meritxell Huch
wiley   +1 more source

Microfluidic Nano‐Assembly of Red‐Blood‐Cell (RBC) Lipids and Components for Engineering Extracellular Vesicles

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 41, 6 November 2026.
Engineered red blood cell‐derived extracellular vesicles (eRBCEVs) are synthesized via controlled microfluidic assembly from native RBC lipids, enabling tunable encapsulation of proteins, nucleic acids, nanoparticles, and viral vectors. The platform demonstrates reproducible nanoscale architecture, preserved membrane composition, and functional cargo ...
Chiranth K. Nagaraj   +23 more
wiley   +1 more source

The Treatment Strategies for Intermediate‐Advanced Hepatocellular Carcinoma Based on Albumin–Bilirubin Grade: A Multicenter Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background To evaluate whether the albumin–bilirubin (ALBI) grade modifies the association of combined locoregional plus systemic therapy versus systemic therapy alone with outcomes in unresectable hepatocellular carcinoma (HCC). Methods This multicente retrospective study enrolled 525 patients, stratified by the established ALBI grade cut‐off
Kang Liang   +9 more
wiley   +1 more source

Benefiting Subgroup From Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma: A Propensity Score‐Matched Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT The survival benefit of adjuvant chemotherapy (ACT) following resection of intrahepatic cholangiocarcinoma (iCCA) remains controversial; moreover, the patient group that could benefit most from this approach remains undetermined. We conducted a retrospective cohort study of 423 patients (median age 65 years; 52.2% male; 297 patients who ...
Yeting Lu   +12 more
wiley   +1 more source

Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues?

open access: yes, 2018
The risk of recurrent hepatitis B virus (HBV) infection and prognosis of liver transplantation in patients with HBV has dramatically changed with the use of prophylaxis including hepatitis B immune globulin (HBIg) and antiviral agents. Methods.
Bilbao, Itxarone   +9 more
core  

Home - About - Disclaimer - Privacy